Detalhe da pesquisa
1.
Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study.
Mod Rheumatol
; 30(3): 442-449, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31106666
2.
Discontinuation of tofacitinib after achieving low disease activity in patients with rheumatoid arthritis: a multicentre, observational study.
Rheumatology (Oxford)
; 56(8): 1293-1301, 2017 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28407099
3.
Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study).
Ann Rheum Dis
; 75(11): 1917-1923, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26733110
4.
Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia.
Mod Rheumatol
; 25(4): 609-14, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25496409
5.
The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database.
Rheumatol Int
; 34(12): 1729-36, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24852650
6.
Addition of another disease-modifying anti-rheumatic drug to methotrexate reduces the flare rate within 2 years after infliximab discontinuation in patients with rheumatoid arthritis: an open, randomized, controlled trial.
Mod Rheumatol
; 24(4): 561-6, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24252035
7.
Efficacy and safety of abatacept in routine care of patients with rheumatoid arthritis: Orencia(®) as Biological Intensive Treatment for RA (ORBIT) study.
Mod Rheumatol
; 24(5): 754-62, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25036232
8.
Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.
Mod Rheumatol
; 24(3): 399-404, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24252045
9.
A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and Japan.
Mod Rheumatol
; 24(4): 572-9, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24320747
10.
A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology.
Mod Rheumatol
; 23(2): 297-303, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22572888
11.
Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis: a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs.
Mod Rheumatol
; 23(2): 284-96, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22588312
12.
Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis.
Mod Rheumatol
; 23(1): 97-103, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22526831
13.
Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules.
Ann Rheum Dis
; 71(11): 1820-6, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22504558
14.
Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study).
Mod Rheumatol
; 22(3): 327-38, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21898074
15.
Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept.
Mod Rheumatol
; 22(2): 186-94, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21901357
16.
Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors.
Mod Rheumatol
; 22(6): 849-58, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22354637
17.
Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors.
Mod Rheumatol
; 22(6): 849-858, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28925305
18.
Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis.
Rheumatol Adv Pract
; 6(3): rkac090, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36407801
19.
Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis.
Ann Rheum Dis
; 70(2): 299-304, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20980704
20.
Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study.
Rheumatology (Oxford)
; 50(10): 1908-15, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21752873